London Research and Development Centre, Agriculture and Agri-Food Canada, London, ON N5V 4T3, Canada.
Department of Chemistry, University of Western Ontario, London, ON N6A 3K7, Canada.
Toxins (Basel). 2022 Sep 28;14(10):672. doi: 10.3390/toxins14100672.
Aflatoxin B is a potent human carcinogen produced by several species of mainly found on nuts and maize. Exposures in parts of Africa, Latin America and Asia can be at multiples, sometimes orders of magnitude above tolerable daily levels. Although human exposure to aflatoxin can be estimated by analysis of the diet, only determination of the serum albumin aflatoxin adduct provides a health-relevant exposure measure. The lack of a reference serum limits interlaboratory method validation and data comparisons. In this study, we synthetically produced AFB-dialdehyde and covalently coupled it to serum albumin in human serum. This synthetic produced aflatoxin-serum reference material was used in conjunction with isotopically labelled internal standards to evaluate sample digestion methods. This showed using sufficient Pronase in the digestion step was critical to ensure complete proteolytic digestion, which occurs within 4 h. Increasing the digestion temperature from 37 °C to 50 °C also provided a benefit to the overall analysis. In addition, the use of dried blood spots and Volumetric Absorptive Microsampling (VAMS) were investigated showing samples stored with VAMS produced equivalent results to serum samples.
黄曲霉毒素 B 是一种由几种真菌产生的强人类致癌物,主要存在于坚果和玉米中。在非洲、拉丁美洲和亚洲的某些地区,人们可能会接触到高出可耐受日摄入量数倍甚至数十倍的黄曲霉毒素。尽管可以通过分析饮食来估计人类接触黄曲霉毒素的情况,但只有测定血清白蛋白黄曲霉毒素加合物才能提供与健康相关的暴露量衡量标准。由于缺乏参考血清,限制了实验室间方法验证和数据比较。在这项研究中,我们合成了黄曲霉毒素 B1 醛,并将其与人血清白蛋白在人血清中进行了共价结合。这种合成的黄曲霉毒素-血清参考物质与同位素标记的内标物一起用于评估样品消化方法。结果表明,在消化步骤中使用足够的蛋白酶至关重要,以确保完全的蛋白水解消化,这一过程在 4 小时内完成。将消化温度从 37°C 提高到 50°C 也对整体分析有好处。此外,还研究了干血斑和体积吸收微采样(VAMS)的应用,结果表明使用 VAMS 储存的样本与血清样本产生的结果相当。
Toxins (Basel). 2022-9-28
Toxins (Basel). 2022-1-14
Anal Sci Adv. 2023-5-18
Toxins (Basel). 2022-1-14
Food Chem Toxicol. 2017-11-23
Food Chem Toxicol. 2016-12
Cancer Epidemiol Biomarkers Prev. 2006-4